Navigation Links
Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria
Date:5/20/2013

MOUNTAIN VIEW, Calif., May 20, 2013 /PRNewswire-iReach/ -- Specific Technologies, today announced the publication of results of the first study demonstrating detection of pathogenic bacteria, including potential bioterrorism agents such as Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention's list of potential bio-threats. This seminal study, conducted in collaboration with the Defence Science and Technology Laboratory, Salisbury (DSTL), United Kingdom, researchers reported 100% bacterial identification accuracy at inoculum concentrations as low as 8 colony-forming units.  The study also demonstrated a simple method to differentiate strains of the same species, including 5 strains of Yersinia pestis and Bacillus anthracis.

(Photo: http://photos.prnewswire.com/prnh/20130520/CG16830)

Current standard practice for identification of pathogenic bacteria requires completion of a culture and then requires additional time consuming molecular or chemical analysis. Specific Technologies has developed a system for identifying microorganisms from their metabolic signature during culture saving precious hours during potentially deadly incidents.

In the event of a suspected release, a rapid and reliable method to identify potential bioterrorism agents would allow a faster public health response. Current bacterial identification methods can be slow and require highly trained personnel to operate sophisticated instruments that are generally too expensive, delicate, or bulky to deploy outside of a dedicated laboratory facility.

Ray Martino a founder and COO of Specific Technologies, commented, "Microorganisms produce a complex mixture of volatile metabolites unique to their species and strain.  Specific Technologies has developed a system for identifying the species and strain from their metabolic signature during culture, saving the delay and cost of molecular or chemical methods that follow culture"

Mr. Martino continued, "The Specific Technologies sensor is small and disposable. The instrumentation is no more than what is found in common smart phones enabling the use of the solution in the field."

The publication in PLOS ONE http://dx.plos.org/10.1371/journal.pone.0062726 is now available.

About Specific Technologies

Specific Technologies has developed in vitro diagnostic systems for rapid identification of microorganisms to diagnose infections that lead to serious medical conditions including sepsis. The company's unique, patented, metabolomic signature technology identifies microorganisms during culture growth before existing technologies based on molecular or chemical tests can be deployed resulting in faster diagnosis with less labor and no additional instruments. Specific Technologies is located in Mountain View, CA.

For additional information on the Company, please visit www.specifictechnologies.net

Media Contact: Anders Berliner , Specific Technologies, 561-659-5400, aberliner@specifictechnologies.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Specific Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
2. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
3. MD Bioproducts releases HLA-B27 subtype specific antibody.
4. Electronic Medical Records Progress from an Enterprise-Centric Solution to a Customer-Specific Application, Finds Frost & Sullivan
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
6. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
7. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
8. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
9. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
10. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
11. Sequenom CMMs MaterniT21 PLUS LDT Now Reporting On Gender-Specific Chromosomal Abnormalities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016 The U.S. Food ... Jardiance (empagliflozin) to reduce the risk of cardiovascular death ... cardiovascular disease. "Cardiovascular disease is a ... diabetes mellitus," said Jean-Marc Guettier , M.D., C.M., ... in FDA,s Center for Drug Evaluation and Research. "Availability ...
(Date:12/2/2016)... 2, 2016 Persistence Market Research ... its upcoming report titled, "Global Market Study on Cardiac Pacemaker: ... of -1.4% between 2016 and 2024". The global cardiac pacemaker ... and this is likely to decline to US$ 3923.8 ... cardiac pacemaker market is anticipated to exhibit a declining ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Market Research titled "Global Market Study on Automated Endoscope Reprocessors: ... Register a CAGR of 8.6% Between 2016 and 2024 " the ... 2015 and is expected to expand at a CAGR of ... market valuation of US$ 1,367.6 Mn by 2024. ...
Breaking Medicine Technology:
(Date:12/5/2016)... , ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the ... Group of New York was founded by James M. Maisel, MD and has been providing ... Shah has always followed a legacy of surpassing expectations amongst her peers. Growing up ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Facial Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic ... Aesthetic & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading ...
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care ... Dallas area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards ... School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors ...
(Date:12/4/2016)... ... 04, 2016 , ... Responsible dental care hinges on regular brushing of the ... results. This important necessity inspired an inventor from Las Vegas, Nev., to design the ... people break or avoid bad techniques of brushing the teeth in order to prevent ...
Breaking Medicine News(10 mins):